Trials / Completed
CompletedNCT05743062
Awe Inducing Elements in Virtual Reality Applications: A Prospective Study of Hospitalized Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 202 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 6 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This is an experimental study to evaluate which aspects of virtual reality (VR) software development can be optimized to increase awe in pediatric perioperative patients and their adult caregivers (e.g., parents, guardians)
Detailed description
Hospitalized pediatric patients, especially those undergoing anesthesia and surgery, experience anxiety and fear, resulting in lack of cooperation, withdrawal, and aggression. These reactions delay medical care and negatively impact patient experience. This is an experimental, prospective study to evaluate which aspects of virtual reality (VR) software development can be optimized to increase awe in pediatric perioperative patients and their adult caregivers. The primary center for this study will be Lucile Packard Children's Hospital Stanford (LPCHS) (located within Stanford University, Palo Alto, CA). After software development, we will evaluate the awe and engagement of pediatric patients after experiencing the novel virtual reality application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Virtual Reality | Virtual reality intervention will be given 6 times in total and each session will last not more than 60 seconds. Participants will be asked to fill out a survey before the intervention to collect the baseline data, after each session of VR intervention and a final survey at the end of the study. |
| OTHER | Control | For case control, participants will service as their self control and no VR intervention will be given at first. Participants will be asked to fill out a survey before the intervention to collect the baseline data. |
Timeline
- Start date
- 2023-06-29
- Primary completion
- 2023-08-03
- Completion
- 2023-08-03
- First posted
- 2023-02-24
- Last updated
- 2024-01-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05743062. Inclusion in this directory is not an endorsement.